“…These results indicate that, despite the cross-species comparison, SIV Vif is still using the canonical poly-ubiquitination and proteasome degradation pathway to purge cells of human A3B. These results mirror prior studies on human A3G and A3F, where 20 and 19 lysines were simultaneously converted to arginine, and the K-less variants resisted Vif-mediated degradation (Albin et al, 2013; Dang et al, 2008; Shao et al, 2010). Since A3B may very well restrict the replication of other viruses, including HBV, HPV, and HTLV (Ahasan et al, 2015; Lucifora et al, 2014; Ooms et al, 2012; Starrett et al, 2016; Starrett et al, 2017; Verhalen et al, 2016; Vieira et al, 2014; Warren et al, 2015), it is likely that additional A3B counteraction strategies exist and that the functional K-free construct described here may be useful as a mechanistic probe.…”